Abstract:Prion diseases are a group of fatal neurodegenerative illnesses, resulting from the conformational conversion of the cellular prion protein (PrPC) into a misfolded form (PrPSc). The formation of neurotoxic soluble prion protein oligomer (PrPO) is regarded as a key step in the development of prion diseases. About 10%-15% of human prion diseases are caused by mutations in the prion protein gene; however, the underlying molecular mechanisms remain unclear. In the present work, we compared the biophysical properties of wild-type (WT) human prion protein 91-231 (WT HuPrP(91-231)) and its disease-associated variants (P105L, D178N, V203I, and Q212P) using several biophysical techniques. In comparison with WT HuPrP(C), the Q212P and D178N variants possessed greatly increased conversion propensities of PrPC into PrPO, while the V203I variant had dramatically decreased conversion propensity. The P105L variant displayed a similar conversion propensity to WT HuPrP(C). Guanidine hydrochloride-induced unfolding experiments ranked the thermodynamic stabilities of these proteins as Q212P < D178N < WT approximate to P105L < V203I. It was thus suggested that the conversion propensities of the prion proteins are closely associated with their thermodynamic stabilities. Furthermore, structural comparison illustrated that Q212P, D178N, and V203I variants underwent larger structural changes compared with WT HuPrP(C), while the P105L variant adopted a similar structure to the WT HuPrP(C). The mutation-induced structural perturbations might change the thermodynamic stabilities of the HuPrP(C) variants, and correspondingly alter the conversion propensities for these prion proteins. Our results extend the mechanistic understanding of prion pathogenesis, and lay the basis for the prevention and treatment of prion diseases.

1H, 13C, 15N Backbone and Side-Chain Resonance Assignments of the Pathogenic G131V Mutant of Human Prion Protein (91-231)

Biophysical Characterization of Oligomerization and Fibrillization of the G131V Pathogenic Mutant of Human Prion Protein.

Structural basis for the complete resistance of the human prion protein mutant G127V to prion disease.

Effects of the Pathogenic Mutation A117V and the Protective Mutation H111S on the Folding and Aggregation of PrP106-126: Insights from Replica Exchange Molecular Dynamics Simulations.

Infection of Prions and Treatment of PrP106–126 Alter the Endogenous Status of Protein 14-3-3 and Trigger the Mitochondrial Apoptosis Possibly via Activating Bax Pathway

Structural and Dynamic Properties of the Human Prion Protein.

Exploring structural and thermodynamic stabilities of human prion protein pathogenic mutants D202N, E211Q and Q217R.

Mutant D178N Prion Protein Converts Spontaneously in RT-QuIC Assay

Influence of the Pathogenic Mutations T188k/R/A on the Structural Stability and Misfolding of Human Prion Protein: Insight from Molecular Dynamics Simulations

Distinct Effects of Mutations on Biophysical Properties of Human Prion Protein Monomers and Oligomers.

Diverse effects on the native β-sheet of the human prion protein due to disease-associated mutations.

Solution Structure and Dynamics of the I214V Mutant of the Rabbit Prion Protein.

N-terminal Prion Protein Peptides (prp(120–144)) Form Parallel In-Register Β-Sheets Via Multiple Nucleation-Dependent Pathways.

Human Prion Disease with a G114V Mutation and Epidemiological Studies in a Chinese Family: a Case Series

Effects of the A117v Mutation on the Folding and Aggregation of Palindromic Sequences (Prp113-120) in Prion: Insights from Replica Exchange Molecular Dynamics Simulations

Manganese-induced Changes of the Biochemical Characteristics of the Recombinant Wild-Type and Mutant PrPs

Structural and Dynamical Mechanisms of a Naturally Occurring Variant of the Human Prion Protein in Preventing Prion Conversion?

Human Prion Disease with a T188K Mutation in Chinese: a Case Report

Molecular Dynamical Simulations of Point Mutation Occurring at the 198-Th Site of Prion Protein

Interaction Between 14-3-3β and PrP Influences the Dimerization of 14-3-3 and Fibrillization of PrP106-126.

The Diversities of PrP(Sc) Distributions and Pathologic Changes in Various Brain Regions from a Chinese Patient with G114V Genetic CJD.